Eric K. Singhi, Assistant Professor at MD Anderson Cancer Center, shared a post on X:
“Borderline resectable NSCLC – the path forward?
- Think biology > anatomy.
- Systemic therapy first.
- Always reassess resectability.
- Don’t label unresectable too early.
- Right patient. Right therapy. Right time.”
Other posts featuring Eric K. Singhi on OncoDaily.